Show simple item record

Probiotics as a potential tool for gynecological cancers prevention and therapy suport

dc.contributor.authorKuźmycz, Olga
dc.contributor.authorWierzbińska, Wiktoria
dc.date.accessioned2024-09-24T10:27:58Z
dc.date.available2024-09-24T10:27:58Z
dc.date.issued2024-09-18
dc.identifier.issn1730-2366
dc.identifier.urihttp://hdl.handle.net/11089/53227
dc.description.abstractThe human body is host to a variety of microbial species that are essential for maintaining general health. About nine percent of these microbial species inhabit the urogenital tract. It is therefore important to establish a symbiotic relationship between the host’s immune system and the microbiota in this region. Disruptions of this symbiosis can contribute to the development of pelvic inflammatory disease (PID), bacterial vaginosis (BV), vaginal candidiasis and/or even gynaecological cancers by promoting the proliferation of infectious agents. The chemotherapeutic agents currently used in cancer treatment are associated with undesirable side effects. Therefore, there is an urgent need for antitumor agents that have minimal toxicity compared to conventional treatments. Furthermore, the use of drugs to prevent or alleviate the side effects of cervical cancer treatment could significantly improve the quality of life of patients undergoing such therapy. In this review, we focus our attention on the potential efficacy of probiotics in both the prevention and therapeutic intervention of neoplasms affecting the genital tract.en
dc.language.isoen
dc.publisherWydawnictwo Uniwersytetu Łódzkiegopl
dc.relation.ispartofseriesActa Universitatis Lodziensis. Folia Biologica et Oecologicaen
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0
dc.subjectLactobacillusen
dc.subjectSaccharomyces cerevisiae var. boulardiien
dc.subjectcervical canceren
dc.subjectmicrobiomeen
dc.titleProbiotics as a potential tool for gynecological cancers prevention and therapy suporten
dc.typeArticle
dc.page.number85-90
dc.contributor.authorAffiliationKuźmycz, Olga - University of Lodz, Faculty of Biology, Department of Molecular Microbiology, Polanden
dc.contributor.authorAffiliationWierzbińska, Wiktoria - University of Lodz, Faculty of Biology, Department of Molecular Microbiology, Poland; BioMedChem Doctoral School of the University of Lodz and Lodz Institutes of the Polish Academy of Sciences, Polanden
dc.identifier.eissn2083-8484
dc.referencesBrooks, J.P., Edwards, D.J., Blithe, D.L., Fettweis, J.M., Serrano, M.G., Sheth, N.U. 2017 Effects of combined oral contraceptives, depot medroxyprogesterone acetate and the levonorgestrel-releasing intrauterine system on the vaginal microbiome. Contraception, 95, 405–413.en
dc.referencesCha, M.K., Lee, D.K., An, H.M., Lee, S.W., Shin, S.H., Kwon, J.H. 2012. Antiviral activity of Bifidobacterium adolescentis SPM1005-a on human papillomavirus type 16. BMC Medicine, 10, 72.en
dc.referencesGarcia-Grau, I., Simon, C., Moreno, M. 2018. Uterine microbiome low biomass and high expectations. Biology of Reproduction, 101(6), 1102–1114.en
dc.referencesJahanshahi, M., Maleki Dana, P., Badehnoosh, B., Asemi, Z., Hallajzadeh, J., Mansournia, M.A., Yousefi, B., Moazzami, B., Chaichian, S. 2020. Anti-tumor activities of probiotics in cervical cancer. Journal of Ovarian Research, 13(1), 68.en
dc.referencesKailasapathy, K., Chin, J. 2000. Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp. Immunology & Cell Biology, 78, 80–88.en
dc.referencesKim, S.N., Lee, W.M., Park, K.S., Kim, J.B., Han, D.J., Bae, J. 2015. The effect of Lactobacillus casei extract on cervical cancer cell lines. Contemporary Oncology (Poznan), 19, 306–312.en
dc.referencesLaniewski, P., Ilhan, Z.E., Herbst-Kralovetz, M.M. 2020. The microbiome and gynaecological cancer development, prevention and therapy. Nature Reviews Urology, 17, 232–250.en
dc.referencesLi, C., Jia, L., Yu, Y., Jin, L. 2019. Lactic acid induced microRNA-744 enhances motility of SiHa cervical cancer cells through targeting ARHGAP5. Chemico-Biological Interactions, 298, 86–95.en
dc.referencesMarkowiak, P., Śliżewska, K. 2017. Effects of probiotics, prebiotics, and synbiotics on human health. Nutrients, 9, 1021.en
dc.referencesNami, Y., Abdullah, N., Haghshenas, B., Radiah, D., Rosli, R., Khosroushahi A.Y. 2014. Assessment of probiotic potential and anticancer activity of newly isolated vaginal bacterium Lactobacillus plantarum 5BL. Microbiology and Immunology, 58(9), 492–502.en
dc.referencesNegi, D., Singh, A., Joshi, N., Mishra, N. 2020. Cisplatin and Probiotic Biomass Loaded Pessaries for the Management of Cervical Cancer. Anti-cancer Agents in Medicinal Chemistry, 20(5), 589–98.en
dc.referencesNené, N.R., Reisel, D., Leimbach, A., Franchi, D., Jones, A., Evans, I. 2019. Association between the cervicovaginal microbiome, BRCA1 mutation status, and risk of ovarian cancer: a case-control study. The Lancet Oncology, 20(8), 1171–1182.en
dc.referencesNouri Z., Karami F., Neyazi N., Modarressi M.H., Karimi R., Khorramizadeh M.R. 2016. Dual anti-metastatic and anti-proliferative activity assessment of two probiotics on HeLa and HT 29 cell lines. Cell Journal, 18(2):127.en
dc.referencesPendharkar, S., Skafte-Holm, A., Simsek, G., Haahr, T. 2023. Lactobacilli and Their Probiotic Effects in the Vagina of Reproductive Age Women. Microorganisms, 11(3):636.en
dc.referencesPericolini, E., Gabrielli, E., Ballet, N., Sabbatini, S., Roselletti, E., Cayzeele Decherf, A., Pélerin, F., Luciano, E., Perito, S., Jüsten, P. 2017. Therapeutic activity of a Saccharomyces cerevisiae-based probiotic and inactivated whole yeast on vaginal candidiasis. Virulence, 8:74–90.en
dc.referencesQi, X., Yun, C., Pang, Y., Qiao, J. 2021. The impact of the gut microbiota on the reproductive and metabolic endocrine system. Gut Microbes, 13(1):1-21.en
dc.referencesRajoka M.S.R., Zhao H., Lu Y., Lian Z., Li N., Hussain N. 2018. Anticancer potential against cervix cancer (HeLa) cell line of probiotic Lactobacillus casei and Lactobacillus paracasei strains isolated from human breast milk. Food & Function, 9(5), 2705–2715.en
dc.referencesRavel, J., Gajer, P., Abdo, Z., Schneider, G.M., Koenig, S.S.K., McCulle, S.L., Karlebach, S., Gorle, R., Russell, J., Tacket, C.O. 2011. Vaginal Microbiome of Reproductive-Age Women. Proceedings of the National Academy of Sciences USA, 108 (Suppl. 1), 4680–4687.en
dc.referencesSambrani, R., Abdolalizadeh, J., Kohan, L., Jafari, B. 2021. Recent advances in the application of probiotic yeasts, particularly Saccharomyces, as an adjuvant therapy in the management of cancer with focus on colorectal cancer. Molecular Biology Reports, 48(1), 951–960.en
dc.referencesShamekhi ,S., Lotfi, H., Abdolalizadeh, J., Bonabi, E., Zarghami, N. 2020. An overview of yeast probiotics as cancer biotherapeutics: possible clinical application in colorectal cancer. Clinical and Translational Oncology, 22(8), 1227–1239.en
dc.referencesSimms, K.T., Steinberg, J., Caruana, M., Smith, M.A., Lew, J.B., Soerjomataram, I. 2019. Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries. The Lancet Oncology, 20(3), 394–407.en
dc.referencesŚliżewska, K., Markowiak-Kopeć, P., Śliżewska, W. 2020. The Role of Probiotics in Cancer Prevention. Cancers (Basel), 23, 13(1):20.en
dc.referencesVilleger, R., Lopes, A., Carrier, G., Veziant, J., Billard, E., Barnich, N. 2019. Intestinal microbiota: a novel target to improve anti-tumor treatment? International Journal of Molecular Sciences, 20, 4584.en
dc.referencesWalther-António, M.R., Chen, J., Multinu, F., Hokenstad, A., Distad, T.J., Cheek, E.H. 2016. Potential contribution of the uterine microbiome in the development of endometrial cancer. Genome Medicine, 8(1):122.en
dc.referencesWang, K. D., Xu, D. J., Wang, B. Y., Yan, D. H., Lv, Z., Su, J. R. 2018 Inhibitory effect of vaginal Lactobacillus supernatants on cervical Cancer cells. Probiotics and Antimicrobial Proteins, 10, 236–242.en
dc.referencesYarbrough, V.L., Winkle, S., Herbst-Kralovetz, M.M. 2015 Antimicrobial Peptides in the Female Reproductive Tract: A Critical Component of the Mucosal Immune Barrier with Physiological and Clinical Implications. Human Reproduction Update, 21(3):353-77.en
dc.referencesZhou, B., Sun, C., Huang, J., Xia, M., Guo, E., Li, N. 2019 The biodiversity composition of microbiome in ovarian carcinoma patients. Scientific Report, 9(1), 1691.en
dc.contributor.authorEmailKuźmycz, Olga - olga.kuzmycz@biol.uni.lodz.pl
dc.contributor.authorEmailWierzbińska, Wiktoria - wiktoria.wierzbinska@edu.uni.lodz.pl
dc.identifier.doi10.18778/1730-2366.18.12
dc.relation.volume18


Files in this item

Thumbnail
Name:
85-90_Kuzmycz_Wierzbinska.pdf
Size:
398.3Kb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record

https://creativecommons.org/licenses/by-nc-nd/4.0
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by-nc-nd/4.0